Lymphoblast-derived integration-free iPS cell line from a female 67-year-old Alzheimer's disease patient with TREM2 (R47H) missense mutation

2Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Human lymphoblast cells from a female patient diagnosed with Alzheimer's disease (AD) possessing the missense mutation TREM2 p.R47H were used to generate integration-free induced pluripotent stem cells (iPSCs) employing episomal plasmids expressing OCT4, SOX2, NANOG, LIN28, c-MYC and L-MYC. The iPSCs retained the TREM2 mutation, and were defined as pluripotent based on (i) expression of pluripotent-associated markers, (ii) embryoid body-based differentiation into cell types representative of the three germ layers and (iii) the similarity between the transcriptomes of the iPSC line and the human embryonic stem cell line H1 with a Pearson correlation of 0.961.

Cite

CITATION STYLE

APA

Schröter, F., Sleegers, K., Cuyvers, E., Bohndorf, M., Wruck, W., Van Broeckhoven, C., & Adjaye, J. (2016). Lymphoblast-derived integration-free iPS cell line from a female 67-year-old Alzheimer’s disease patient with TREM2 (R47H) missense mutation. Stem Cell Research, 17(3), 553–555. https://doi.org/10.1016/j.scr.2016.10.005

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free